Home » Topics » BioWorld Science

BioWorld Science
RSS

Shanghai Jemincare Pharmaceuticals, Jiangxi Jemincare Group present factor XIa inhibitors

Jan. 20, 2021

Organ-on-a-chip bests standard toxicity tests

Jan. 20, 2021

IMPACT Therapeutics identifies ATR kinase inhibitors

Jan. 20, 2021

Shanghai Pharmaceuticals Holding patents Wee1-like protein kinase inhibitors

Jan. 20, 2021

ZM-32, a novel muscone derivative that inhibits breast tumor angiogenesis in vivo

Jan. 20, 2021

New IL-17 modulators discovered at UCB

Jan. 20, 2021

Bayer synthesizes new P2X3 receptor antagonists

Jan. 20, 2021

Ivermectin found useful in patients with nonsevere COVID-19 disease

Jan. 20, 2021

European Commission approves Enhertu for HER2-positive breast cancer

Jan. 20, 2021

FDA clears IND application for TERN-501 to be developed as treatment for NASH

Jan. 20, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...